Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer
| Journal | Volume 84 - 2021 |
| Issue | Fasc.4 - Case reports |
| Author(s) | L. Bricman 1, P. Yengue 1, C. Miscu 1, S. Junius 2, F. Waignein 3, J-M. Vandenbulcke 4 |
| Full article |
 PAGES 663-665 VIEW FREE PDF |
| DOI | 10.51821/84.4.018 |
|
Affiliations: (1) Department of Gastroenterology, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium
(2) Department of Radiotherapy, Centre Hospitalier de Mouscron, Belgium (3) Department of Anatomopathology, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium (4) Department of Oncology, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium |
|
Plasmablastic lymphoma (PBL) represents a rare and aggressive subtype of diffuse large B cells lymphoma (DLBCL) most associated with the human immunodeficiency virus (HIV). Prognosis remains poor despite various treatment approaches. We describe an evolution at six months of HIV negative PBL and Ebstein Barr virus (EBV) positive PBL with chemotherapy. Role of radiotherapy is still unclear. Keywords: plasmablastic lymphoma, Ebstein Barr virus, rectal bleeding, external radiotherapy, chemotherapy. |
| The authors declare that they have no conflict of interest. |
|
© Acta Gastro-Enterologica Belgica. PMID 34965049 |
